Font Size: a A A

Study Of SerumOPG, SRANKL Concentrations In Patients With Acute Coronary Syndrom

Posted on:2009-08-20Degree:MasterType:Thesis
Country:ChinaCandidate:Q H ZhongFull Text:PDF
GTID:2144360245982548Subject:Cardiovascular medicine
Abstract/Summary:PDF Full Text Request
Objective:To determine the serum levels of OPG and sRANKL in patients with acute coronary syndrom(ACS)and estimate the relationship between ACS and the concentrations of OPG and sRANKL.Methods:25 patients with acute coronary syndrome(ACS)and 25 patients with stable angina pectoris were included.Another 25 patients without cronary heart disease(CHD)were selected as control group.All the patients underwent coronary angiography and the Gensini score were used to assess the severity of the coronary stenosis.The levels of OPG and sRANKL in serum were measured by enzyme-linked immunosorbent assay (ELISA).The concentrations of high sensitive C reactive protein(hs-CRP) and low density lipoprotein cholesterol(LDL-C)were also analysed.Result:The levels of OPG were significantly higher in patients with ACS than those of patients with stable angina pectoris and control group (P<0.01).The levels of sRANKL were obviously decreased in patients with ACS than those of patients with stable angina pectoris and control group(P<0.01).The levels of OPG in patients with coronary heart disease were positively correlated with the levels of hs-CRP, Gensini score(P<0.05).The levels of sRANKL and Gensini score, hs-CRP negatively correlated(P<0.01),and neither were correlated with the concentrations of LDL-C in plasma(P>0.05).Conclusion:The higher levels of OPG and lower levels of sRANKL in ACS patients,the stronger the inflammatory response in atherosclerotic plaque.Therefore,both of them can indicate the plaque instability.
Keywords/Search Tags:acute coronary syndrome, atherosclerosis, osteoprotegenn, soluble ligand of receptor activator Of NF-κB, ligand of receptor activator Of NF-κB
PDF Full Text Request
Related items
Correlative Study On The Relationship Between Serum OPG And SRANKL And Coronary Heart Disease
Expression Of Soluble Receptor Activator Of Nuclear Factor-κb Ligand And Osteoprotegerin In Adolescent Idiopathic Scoliosis Patients At The Osteoblast Level
Effects Of Combination With Parathyroid And β-blocker On The Proliferation, Osteoprotegin And Receptor Activator Of NF-κB Ligand Gene Expression In Human Osteoblasts
Cloning, Expression And Bioactivity Analysis The Active Domain Of Mouse Receptor Activator Of NF-κB Ligand (mRANKL)
Correlation Between NF-kappaB (NF-κB), Receptor Activator Of NFkappaB Ligand (RANKL) And Matrix Metalloproteinase-9 (MMP-9) Expression In Synovium Of Collagen-induced Arthritis Rats
Part I The Relative Expression Of Receptor Activator Of Nuclear Factor-Kappa B Ligand And Osteoprtegerin MRNA In Bone Tissue In Ovariectomized Mice
Association Of Receptor Activator Of NF-κB Ligand Gene And Osteoprotegerin Gene Polymorphisms With Susceptibility To Ankylosing Spondylitis In A Chinese Han Population; A Case-control Study
Association Between Serum Osteoprotegerin/Receptor Activator Of Nuclear Factor KappaB Ligand,25-(OH)VitD3Levels And Osteoporosis With Type2Diabetes Mellitus
The Study Of Relationship Between Expression Level Of Receptor Activator Of NF-kappa B Ligand MRNA In Peripheral Blood Mononuclear Cell And Renal Osteodystrophy In Maintenance Hemodialysis Patients
10 Effects Of Pinoresinol Di-O-β-D-glucopyranoside On The Expressions Of Receptor Activator Of Nuclear Factor-κB Ligand And Osteoprotegerin In Murine Osteoblasts MC3T3-E1in Vitro